Evaluating surrogacy metrics and investigating approval decisions of progression-free survival (PFS) in metastatic renal cell cancer: a systematic review.
about
Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysisModel-based prediction of progression-free survival in patients with first-line renal cell carcinoma using week 8 tumor size change from baseline.Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy.Strength of Validation for Surrogate End Points Used in the US Food and Drug Administration's Approval of Oncology Drugs.
P2860
Evaluating surrogacy metrics and investigating approval decisions of progression-free survival (PFS) in metastatic renal cell cancer: a systematic review.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Evaluating surrogacy metrics a ...... l cancer: a systematic review.
@en
type
label
Evaluating surrogacy metrics a ...... l cancer: a systematic review.
@en
prefLabel
Evaluating surrogacy metrics a ...... l cancer: a systematic review.
@en
P2093
P2860
P356
P1433
P1476
Evaluating surrogacy metrics a ...... l cancer: a systematic review.
@en
P2093
K R Johnson
M N D Lassere
P2860
P304
P356
10.1093/ANNONC/MDU267
P577
2014-07-23T00:00:00Z